Rohan Palekar
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Rohan Palekar currently works at 89bio, Inc., as Chief Executive Officer from 2025, Aim High For High School, as Chairman, and Neurogene, Inc., as Independent Director from 2023.
Mr. Palekar also formerly worked at Avanir Pharmaceuticals, Inc., as President & Chief Executive Officer from 2016 to 2017, Xenerex Biosciences, as Chief Executive Officer, Neoleukin Therapeutics, Inc., as Independent Director from 2022 to 2023, Centocor, Inc., as Vice President-Dermatology Sales & Marketing from 2001 to 2007, and Medivation LLC (California), as Chief Commercial Officer from 2008 to 2011.
Mr. Palekar received his undergraduate degree and graduate degree from the University of Mumbai and Masters Business Admin degree from Tuck School of Business at Dartmouth.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 07/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| 89BIO, INC. | Directeur Général | 01/06/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
| NEUROGENE INC. | Directeur/Membre du Conseil | 01/12/2023 |
| AVANIR PHARMACEUTICALS INC | Directeur Général | 31/12/2017 |
| MEDIVATION INC | Corporate Officer/Principal | 09/09/2011 |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Sales & Marketing | 01/12/2007 |
Xenerex Biosciences
Xenerex Biosciences Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing human monoclonal antibodies | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Xenerex Biosciences
Xenerex Biosciences Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing human monoclonal antibodies | Commercial Services |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
89bio, Inc.
89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Neoleukin Therapeutics, Inc.
Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Develops de novo – therapeutic proteins to treat serious immunological disorders, including cancer and autoimmunity | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national